{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:55:51Z","timestamp":1793051751405,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.reprotox.2024.108561","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T11:30:09Z","timestamp":1709033409000},"page":"108561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Pregnancy outcomes and birth defects in offspring following Non-steroidal anti-inflammatory drugs exposure during\u00a0pregnancy: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"125","author":[{"given":"Xiaohong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2024.108561_bib1","unstructured":"Z. Aikaterini, R.T. Mitchell, D.C. Hay, P.A. Fowler, Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety, Human Reproduction Update (2020)."},{"key":"10.1016\/j.reprotox.2024.108561_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.reprotox.2018.02.007","article-title":"30Safety of diclofenac use during early pregnancy: a prospective observational cohort study","volume":"77","author":"Padberg","year":"2018","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108561_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/bdrb.20085","article-title":"11Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study","volume":"77","author":"Ofori","year":"2006","journal-title":"Birth Defects Res B Dev. Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108561_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00228-021-03222-w","article-title":"Maternal non-steroidal anti-inflammatory drug exposure during pregnancy and risk of miscarriage: a systematic review and meta-analysis","volume":"78","author":"Ying","year":"2022","journal-title":"Eur. J. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108561_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/humupd\/dmaa042","article-title":"Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety","volume":"27","author":"Zafeiri","year":"2021","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.reprotox.2024.108561_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3892\/ol.2016.5448","article-title":"Host knockout of E-prostanoid 2 receptors reduces tumor growth and causes major alterations of gene expression in prostaglandin E(2)-producing tumors","volume":"13","author":"Asting","year":"2017","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108561_bib7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108561_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1542\/peds.107.3.519","article-title":"Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn","volume":"107","author":"Alano","year":"2001","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.reprotox.2024.108561_bib9","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1124\/dmd.108.024349","article-title":"Transplacental pharmacokinetics of diclofenac in perfused human placenta","volume":"37","author":"Shintaku","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.reprotox.2024.108561_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/01.ogx.0000544556.43877.8f","article-title":"Ibuprofen Is Deleterious for the Development of First-Trimester Human Fetal Ovary Ex Vivo","volume":"73","author":"Leverrier-Penna","year":"2018","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.reprotox.2024.108561_bib11","unstructured":"Prenatal acetaminophen use and outcomes in children, American Journal of Obstetrics & Gynecology (2017)."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108561_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1586\/17512433.1.5.605","article-title":"Major malformations after first trimester exposure to aspirin and NSAIDs","volume":"1","author":"Nakhai-Pour","year":"2008","journal-title":"Expert Rev. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108561_bib13","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108561_bib14","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.reprotox.2024.108561_bib15","unstructured":"EUROCAT, European surveillance of congenital anomalies. Accessed September 2021., Available from: \u3008https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat_en\u3009."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108561_bib16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/AOG.0000000000004714","article-title":"Exposure to tramadol during early pregnancy and risk of spontaneous abortion or major congenital malformations","volume":"139","author":"S\u00f8rensen","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2024.108561_bib17","unstructured":"G.A. Wells, B.J. Shea, D. O'Connell, J. Peterson, P. Tugwell, The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis, (2000)."},{"key":"10.1016\/j.reprotox.2024.108561_bib18","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","author":"Odutayo","year":"2016","journal-title":"BMJ 354"},{"issue":"1","key":"10.1016\/j.reprotox.2024.108561_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajcn\/nqz349","article-title":"Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies","volume":"112","author":"Li","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.reprotox.2024.108561_bib20","unstructured":"K.J. Rothman, S. Greenland, T.L. Lash, Modern epidemiology: Third edition, (2011)."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108561_bib21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"24","key":"10.1016\/j.reprotox.2024.108561_bib22","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM198912143212404","article-title":"The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects","volume":"321","author":"Werler","year":"1989","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108561_bib23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1479-828X.1991.tb02816.x","article-title":"Use of Prescription Drugs in the First Trimester and Congenital Malformations","volume":"31","author":"Correy","year":"1991","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108561_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4","article-title":"Maternal medications and environmental exposures as risk factors for gastroschisis","volume":"54","author":"Torfs","year":"1996","journal-title":"Teratology"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108561_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1096-9926(199710)56:4<241::AID-TERA2>3.0.CO;2-1","article-title":"Prenatal exposure to salicylates and gastroschisis: a case-control study","volume":"56","author":"Mart\u00ednez-Fr\u00edas","year":"1997","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2024.108561_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/1099-1557(200005\/06)9:3<193::AID-PDS498>3.0.CO;2-I","article-title":"A population-based case\u2013control teratologic study of acetylsalicylic acid treatments during pregnancy","author":"Czeizel","year":"2000","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"7281","key":"10.1016\/j.reprotox.2024.108561_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","article-title":"Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study","volume":"322","author":"Nielsen","year":"2001","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.reprotox.2024.108561_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0890-6238(03)00012-1","article-title":"Maternal drug use in early pregnancy and infant cardiovascular defect","volume":"17","author":"K\u00e4ll\u00e9n","year":"2003","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108561_bib29","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","article-title":"Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study","volume":"192","author":"Nrgrd","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108561_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00002018-200730010-00006","article-title":"A population-based case-control teratologic study of oral dipyrone treatment during pregnancy","volume":"30","author":"B\u00e1nhidy","year":"2007","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108561_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00404-008-0707-3","article-title":"Dipyrone use during pregnancy and adverse perinatal events","volume":"279","author":"Pizzol","year":"2008","journal-title":"Arch. Gynecol."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108561_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022174","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study","volume":"6","author":"van Gelder","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.reprotox.2024.108561_bib33","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3899\/jrheum.120453","article-title":"Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy","volume":"39","author":"Daniel","year":"2012","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.reprotox.2024.108561_bib34","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/1471-0528.12192","article-title":"Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study","volume":"120","author":"Nezvalov\u00e1-Henriksen","year":"2013","journal-title":"Bjog"},{"issue":"10","key":"10.1016\/j.reprotox.2024.108561_bib35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.annepidem.2017.09.003","article-title":"Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011","volume":"27","author":"Interrante","year":"2017","journal-title":"Ann. Epidemiol."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108561_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s12325-018-0735-8","article-title":"Use of nimesulide during early pregnancy and the risk of congenital malformations: a population-based study from Italy","volume":"35","author":"Cantarutti","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.reprotox.2024.108561_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.reprotox.2018.05.003","article-title":"No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester - Evaluation of the national Embryotox cohort","volume":"79","author":"Dathe","year":"2018","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108561_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00228-017-2385-1","article-title":"Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study","volume":"74","author":"Dathe","year":"2018","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.reprotox.2024.108561_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijporl.2018.09.033","article-title":"Maternal risk factors for severe microtia\/atresia in China: a case-control study","volume":"115","author":"Liu","year":"2018","journal-title":"Int. J. Pedia Otorhinolaryngol."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108561_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048092","article-title":"Maternal over-the-counter analgesics use during pregnancy and adverse perinatal outcomes: cohort study of 151\u2009141 singleton pregnancies","volume":"12","author":"Zafeiri","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.reprotox.2024.108561_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/aje\/155.1.26","article-title":"Maternal medication use and risks of gastroschisis and small intestinal Atresia","author":"Werler","year":"2002","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108561_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.reprotox.2010.04.010","article-title":"First trimester diclofenac exposure and pregnancy outcome","volume":"30","author":"Cassina","year":"2010","journal-title":"Reprod. Toxicol."},{"issue":"5748","key":"10.1016\/j.reprotox.2024.108561_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.1.5748.523","article-title":"Associations between drugs administered during pregnancy and congenital abnormalities of the fetus","volume":"1","author":"Nelson","year":"1971","journal-title":"BMJ"},{"key":"10.1016\/j.reprotox.2024.108561_bib44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/978-1-4684-3219-0_38","article-title":"A retrospective enquiry into possible teratogenic effects of drugs in pregnancy","author":"Richards","year":"1972","journal-title":"Adv. Exp. Med. Biol. 27"},{"issue":"7974","key":"10.1016\/j.reprotox.2024.108561_bib45","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)93025-7","article-title":"Aspirin and congenital malformations","volume":"307","author":"Slone","year":"1976","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.reprotox.2024.108561_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM198508083130603","article-title":"Congenital heart disease in relation to maternal use of bendectin and other drugs in early pregnancy","volume":"313","author":"Zierler","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2024.108561_bib47","doi-asserted-by":"crossref","unstructured":"M.M. Werler, A.A. Mitchell, S. Samuel, First Trimester Maternal Medication Use in Relation to Gastroschisis, Obstetrical & Gynecological Survey (1992).","DOI":"10.1097\/00006254-199211000-00002"},{"issue":"3","key":"10.1016\/j.reprotox.2024.108561_bib48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.aje.a117243","article-title":"Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study","volume":"140","author":"Lynberg","year":"1994","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2024.108561_bib49","doi-asserted-by":"crossref","unstructured":"E.S. Draper, R. Judith, A.M. Tonks, K.R. Abrams, D.J. Field, C. Michael, J.J. Kurinczuk, Recreational Drug Use: A Major Risk Factor for Gastroschisis?, Obstetrical & Gynecological Survey (2008).","DOI":"10.1097\/01.ogx.0000316302.91665.6b"},{"issue":"2","key":"10.1016\/j.reprotox.2024.108561_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004183","article-title":"Neonatal and maternal adverse outcomes and exposure to nonsteroidal anti-inflammatory drugs during early pregnancy in South Korea: a nationwide cohort study","volume":"20","author":"Choi","year":"2023","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.reprotox.2024.108561_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/AOG.0b013e3182595671","article-title":"Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion","volume":"120","author":"Edwards","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"7411","key":"10.1016\/j.reprotox.2024.108561_bib52","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.reprotox.2024.108561_bib53","doi-asserted-by":"crossref","first-page":"275.e1","DOI":"10.1016\/j.ajog.2018.06.002","article-title":"Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage","volume":"219","author":"Li","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"15","key":"10.1016\/j.reprotox.2024.108561_bib54","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1503\/cmaj.110454","article-title":"Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion","volume":"183","author":"Nakhai-Pour","year":"2011","journal-title":"Cmaj"},{"issue":"5","key":"10.1016\/j.reprotox.2024.108561_bib55","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1503\/cmaj.130605","article-title":"Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions","volume":"186","author":"Daniel","year":"2014","journal-title":"Cmaj"},{"issue":"5","key":"10.1016\/j.reprotox.2024.108561_bib56","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/j.pain.0000000000001163","article-title":"Risk of preterm birth following late pregnancy exposure to NSAIDs or COX-2 inhibitors","volume":"159","author":"B\u00e9rard","year":"2018","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.reprotox.2024.108561_bib57","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/1471-0528.16670","article-title":"Early exposure of pregnant women to non-steroidal anti-inflammatory drugs delivered outside hospitals and preterm birth risk: nationwide cohort study","volume":"128","author":"Quantin","year":"2021","journal-title":"Bjog"},{"key":"10.1016\/j.reprotox.2024.108561_bib58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-90-481-9485-8_20","article-title":"The prevalence of congenital anomalies in Europe","author":"Dolk","year":"2010","journal-title":"Adv. Exp. Med Biol. 686"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108561_bib59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0890-6238(01)00137-X","article-title":"Nonsteroidal anti-inflammatory drugs in early pregnancy","volume":"15","author":"Ericson","year":"2001","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2024.108561_bib60","doi-asserted-by":"crossref","unstructured":"M.A. ClevesS.V. Jr, S. Raj, W. Zhao, A. Correa, M.M. Werler, C.A. Hobbs, N.B.D.P. Study, Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects 3 ( 70 Birth Defects Res. Part A Clin. Mol. Teratol2004, 107.","DOI":"10.1002\/bdra.20005"},{"issue":"3","key":"10.1016\/j.reprotox.2024.108561_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.11.019","article-title":"Nonsteroidal antiinflammatory drug use among women and the risk of birth defects","volume":"206","author":"Hernandez","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2024.108561_bib62","doi-asserted-by":"crossref","unstructured":"Paul, C., Gillette, Genetic and environmental risk factors of major cardiovascular malformations: The baltimore\u2013washington infant study: 1981\u20131989 edited by Charlotte Ferencz, Adolfo Correa\u2013Villasenor, Christopher A. Loffredo, P. David Wilson, Futura Publishing Company, Clinical Cardiology (1998).","DOI":"10.1002\/clc.4960211122"},{"key":"10.1016\/j.reprotox.2024.108561_bib63","first-page":"47","article-title":"Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure","volume":"68","author":"Cappon","year":"2003"},{"issue":"10","key":"10.1016\/j.reprotox.2024.108561_bib64","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/009127000004001005","article-title":"Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in Healthy Volunteers","volume":"40","author":"van Hecken","year":"2000","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108561_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-5793(79)81371-X","article-title":"Advances in prostaglandin and thromboxane research","volume":"103","author":"Hoult","year":"1979","journal-title":"FEBS Lett."},{"key":"10.1016\/j.reprotox.2024.108561_bib66","unstructured":"C. Davis, Studies on identification of the causative agent in aspirin teratogenesis in the rat, (1970)."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108561_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.2012-0496","article-title":"Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn","volume":"131","author":"Van Marter","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.reprotox.2024.108561_bib68","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.aje.a117243","article-title":"Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study","author":"Lynberg","year":"1994","journal-title":"Am. J. Epidemiol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623824000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623824000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:02:25Z","timestamp":1760191345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623824000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":68,"alternative-id":["S0890623824000285"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2024.108561","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcomes and birth defects in offspring following Non-steroidal anti-inflammatory drugs exposure during\u00a0pregnancy: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2024.108561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108561"}}